+ Reply to Thread
Page 3 of 4 FirstFirst 1 2 3 4 LastLast
Results 21 to 30 of 38

Thread: Kythera deal

  1. #21
    Senior Member
    Join Date
    Sep 2014
    Posts
    584

    Default

    Quote Originally Posted by Sogeking View Post
    Yes I'm with you on this. I do hope it will speed up the release of Seti. But on some acquisitions, development of some drugs were known to be buried. Time will tell I guess.
    They mentioned in their conference call today, specifically stating how excited they are to develop setipiprant.

  2. #22
    Member
    Join Date
    Jun 2015
    Posts
    86

    Default

    Are there any officially anticipated dates when it comes to commercialisation of Setipiprant? It is in which trial phase actually?

  3. #23
    Senior Member
    Join Date
    Nov 2012
    Posts
    1,568

    Default

    Most important thing is just timelines that both things keep moving and get to the finish line. Mergers can throw things into limbo sometimes although it seems pretty unlikely here.

  4. #24
    Senior Member
    Join Date
    Sep 2014
    Posts
    148

    Default

    Quote Originally Posted by Arieux View Post
    Are there any officially anticipated dates when it comes to commercialisation of Setipiprant? It is in which trial phase actually?
    Setipiprant has completed Phase 3 for asthma. I believe Kythera stated they would start in Phase 2 for hair loss.

    Here is an interesting quote: "Combination Therapy: The true Holy Grail may come from combining a drug like Latisse with a certain type of medication commonly used to treat allergies and asthma. The medication blocks a hormone-like substance that prevents hair from growing. A treatment like this might help with hair growth. 'Using these drugs in combination is like taking your foot off-break and stepping on gas at the same time,' Washenik says. "

    http://www.webmd.com/skin-problems-a...ments-pipeline

    The negotiations of this merger probably played a role in Allergan not releasing the Bimatoprost results yet. I wonder how they are going to proceed now. Phase 3 for bim and Phase 2 for setipiprant and get them both approved separately? A phase 2 with the combination compared against Bim by itself? Or maybe a Phase 3 combination somehow?

  5. #25
    Member
    Join Date
    May 2013
    Posts
    93

    Default

    This is great news, in the conference call they said that they will speed up the double chin drug thing and file ind for setipiprant soon

  6. #26
    Senior Member
    Join Date
    Sep 2014
    Posts
    584

    Default

    Just a thought - This deal with Kythera is mostly to do with Allergan wanting to dominate the aesthetics market of the entire head. This includes the injectables for the face, and with the move to acquire Seti, they will cover hair loss as well. In order to cover hair loss properly, they will need a drug that works very well to stop it (seti), as well as a drug that's effective in regrowing (bim).

    This was a genius move. I hope we'll hear something about bimatoprost soon. It's understandable why they'd want both Kybella and Seti, but in most cases bim and seti will be co-dependent. Anyone who starts losing hair, or has hair thin out, and stops it with Seti, will want their full head of hair back. They get a prescription for seti, apply some bim, and it's over.

    The CEO didn't speak much about seti, because it's his job to present the case to shareholders and investors why they made the move on the drug that's already been proven in clinical trials.

    Another point - both are dependent on prostaglandin science. When phase 2b was over for bim, Kythera soon after announced trials for seti. Many people at Kythera used to work for Allergan, therefore it's very likely they were in communication. Allergan then buys Kythera, and plans to develop seti, even though it's the first "hypothesis-driven" approach to drug development AND many MPB drugs have failed up to this point. They know seti will work because of the results they've seen from bim, but also because of the work and science that Cotsarelis has presented.

    One last exciting point - there is a bill that was passed unanimously (51-0) by the Energy and Commerce committee in a very bi-partisan fashion (rare these days). This bill is known as the "21st Century Cures Act." It plans to do, among other things, speed up the clinical trial process by modernizing and streamlining from the time of discovery through to the time it gets to market. It's soon going to be presented to congress, and should very likely be passed. If signed into law, it's likely that the clinical trial process for a drug like setipiprant will be accelerated.

  7. #27
    Senior Member
    Join Date
    May 2012
    Posts
    4,423

    Default

    Quote Originally Posted by It's2014ComeOnAlready View Post
    Just a thought - This deal with Kythera is mostly to do with Allergan wanting to dominate the aesthetics market of the entire head. This includes the injectables for the face, and with the move to acquire Seti, they will cover hair loss as well. In order to cover hair loss properly, they will need a drug that works very well to stop it (seti), as well as a drug that's effective in regrowing (bim).

    This was a genius move. I hope we'll hear something about bimatoprost soon. It's understandable why they'd want both Kybella and Seti, but in most cases bim and seti will be co-dependent. Anyone who starts losing hair, or has hair thin out, and stops it with Seti, will want their full head of hair back. They get a prescription for seti, apply some bim, and it's over.

    The CEO didn't speak much about seti, because it's his job to present the case to shareholders and investors why they made the move on the drug that's already been proven in clinical trials.

    Another point - both are dependent on prostaglandin science. When phase 2b was over for bim, Kythera soon after announced trials for seti. Many people at Kythera used to work for Allergan, therefore it's very likely they were in communication. Allergan then buys Kythera, and plans to develop seti, even though it's the first "hypothesis-driven" approach to drug development AND many MPB drugs have failed up to this point. They know seti will work because of the results they've seen from bim, but also because of the work and science that Cotsarelis has presented.

    One last exciting point - there is a bill that was passed unanimously (51-0) by the Energy and Commerce committee in a very bi-partisan fashion (rare these days). This bill is known as the "21st Century Cures Act." It plans to do, among other things, speed up the clinical trial process by modernizing and streamlining from the time of discovery through to the time it gets to market. It's soon going to be presented to congress, and should very likely be passed. If signed into law, it's likely that the clinical trial process for a drug like setipiprant will be accelerated.
    Many of us, no wait.... damn near all of us don't or won't give a rats ass about accelerating setipirant as a hair loss treatment. Just release it already. The same goes for Follica and anything to do with stem cells.

  8. #28
    Senior Member
    Join Date
    Feb 2015
    Posts
    355

    Default

    Quote Originally Posted by It's2014ComeOnAlready View Post
    Just a thought - This deal with Kythera is mostly to do with Allergan wanting to dominate the aesthetics market of the entire head. This includes the injectables for the face, and with the move to acquire Seti, they will cover hair loss as well. In order to cover hair loss properly, they will need a drug that works very well to stop it (seti), as well as a drug that's effective in regrowing (bim).

    This was a genius move. I hope we'll hear something about bimatoprost soon. It's understandable why they'd want both Kybella and Seti, but in most cases bim and seti will be co-dependent. Anyone who starts losing hair, or has hair thin out, and stops it with Seti, will want their full head of hair back. They get a prescription for seti, apply some bim, and it's over.

    The CEO didn't speak much about seti, because it's his job to present the case to shareholders and investors why they made the move on the drug that's already been proven in clinical trials.

    Another point - both are dependent on prostaglandin science. When phase 2b was over for bim, Kythera soon after announced trials for seti. Many people at Kythera used to work for Allergan, therefore it's very likely they were in communication. Allergan then buys Kythera, and plans to develop seti, even though it's the first "hypothesis-driven" approach to drug development AND many MPB drugs have failed up to this point. They know seti will work because of the results they've seen from bim, but also because of the work and science that Cotsarelis has presented.

    One last exciting point - there is a bill that was passed unanimously (51-0) by the Energy and Commerce committee in a very bi-partisan fashion (rare these days). This bill is known as the "21st Century Cures Act." It plans to do, among other things, speed up the clinical trial process by modernizing and streamlining from the time of discovery through to the time it gets to market. It's soon going to be presented to congress, and should very likely be passed. If signed into law, it's likely that the clinical trial process for a drug like setipiprant will be accelerated.
    I like it when you talk dirty, it's2014comeonalready

    J.k, but yeah I recently read about that bill being presented to congress. This is really great news. Thanks for that update man, much appreciated and well related.

  9. #29
    Senior Member
    Join Date
    Feb 2015
    Posts
    355

    Default

    I just wish that we knew how effective bim is from the trials. clearly that research that kythera did 2 years before announcing setipriprant was VERY promising.

  10. #30
    Senior Member
    Join Date
    Sep 2014
    Posts
    584

    Default

    I'm not hopelessly optimistic, because I've been losing my hair for long enough (3 years). But, I gotta say, it really looks like things are falling into place.

Similar Threads

  1. Allergan buying Kythera
    By nave13579 in forum Cutting Edge / Future Treatments
    Replies: 0
    Last Post: 06-17-2015, 06:37 AM
  2. Kythera - KYTH-105 (setipiprant), other drug now approved (ATX-101)
    By HairlossAt15 in forum Cutting Edge / Future Treatments
    Replies: 25
    Last Post: 05-03-2015, 11:01 AM
  3. Kythera Conference Call Tomorrow
    By KO1 in forum Cutting Edge / Future Treatments
    Replies: 56
    Last Post: 04-11-2015, 10:25 AM
  4. Whoa - Kythera stock up over 20% this AM
    By RockyMtn in forum Cutting Edge / Future Treatments
    Replies: 12
    Last Post: 03-10-2015, 11:57 AM
  5. kythera news
    By sdsurfin in forum Cutting Edge / Future Treatments
    Replies: 40
    Last Post: 02-12-2015, 10:47 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth

» Recent Threads

Benefits of Resveratrol for hair and health
05-05-2022 01:46 AM
Last Post By felixten
Yesterday 11:59 PM
1800 graft repair case results by Dr. Lindsey
03-27-2024 08:38 AM
Last Post By Dr. Lindsey
03-27-2024 08:38 AM
Navigating the German Job Market as a Kenyan Citizen
11-04-2023 06:31 AM
Last Post By Keegan212
03-27-2024 03:51 AM
DR HAKAN DOGANAY/ 4500 GRAFTS / Implanter Pen+FUE
03-26-2024 04:15 PM
Last Post By Hakan Doganay, MD
03-26-2024 04:15 PM